To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

JAMES Wylie felt perfectly well – until a routine blood test sounded the alarm and revealed a cancer that could have killed ...

HIGHLIGHTSFollowing an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

A month after revealing he has prostate cancer, Shaka Hislop remains the safe pair of hands keeping attackers at bay.

Eddie Gutierrez, who has been receiving treatment in Singapore for his prostate condition, has nothing but gratitude as he is ...

BAYRY jumps 6.6% after partner Orion said Nubeqa sales tied to Bayer could top ???1B long term. Bayer also announced pharma ...

Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...